Skip to main content

Type 2 diabetes and metabolic surgery

medwireNews

Gastric bypass surgery (used with permission)

07-28-2023 | Type 2 diabetes | News

Better QoL after gastric bypass than sleeve gastrectomy for people with type 2 diabetes

Patients undergoing gastric bypass experience superior patient-reported outcomes, diabetes remission rates and weight loss compared with sleeve gastrectomy.

08-12-2022 | Metabolic surgery | News

Use of sleeve gastrectomy may be valid for some people with class 1 obesity

Study findings published in JAMA Network Open suggest that for people with class 1 obesity, sleeve gastrectomy is associated with greater weight loss and diabetes remission than lifestyle intervention, but the procedure is also linked to increased incidence of substance use disorder and self-harm.

08-05-2022 | Obesity | News

Endoscopic sleeve gastroplasty MERITs consideration for mild-to-moderate obesity

People with mild-to-moderate obesity who undergo minimally invasive endoscopic sleeve gastroplasty in addition to lifestyle intervention achieve greater weight loss and metabolic improvements than those undergoing lifestyle modification alone, show the MERIT trial results.

04-22-2022 | Metabolic surgery | News

Benefits of metabolic surgery persist for at least 3 years

People are much more likely to achieve lasting type 2 diabetes remission with surgical rather than medical intervention, even if they have only mild obesity, shows 3-year follow-up of four randomized trials.

02-17-2022 | Metabolic surgery | News

Type 2 diabetes subtypes may determine bariatric surgery outcomes

People in different type 2 diabetes subgroups may experience varying levels of improvement after bariatric surgery, with those in the severe insulin-resistant diabetes group most likely to benefit, study findings indicate.

12-13-2021 | Metabolic surgery | News

Weight-loss surgery associated with decreased cancer risk in obese people with type 2 diabetes

Findings from the prospective Swedish Obese Subjects study suggest that bariatric surgery in people with concomitant type 2 diabetes and obesity is linked to a lower cancer incidence than conventional obesity treatment.

11-29-2021 | Metabolic surgery | News

Rival gastric surgery approaches have similar effects on liver fat

Gastric bypass and sleeve gastrectomy both result in “almost complete clearance of liver fat” within a year after the intervention, show secondary outcomes of a randomized trial.

11-02-2021 | Type 2 diabetes | News

One in 20 may achieve type 2 diabetes remission in routine care

Researchers have found evidence that almost one in 20 people diagnosed with type 2 diabetes in routine clinical care later achieve remission.

09-17-2021 | Metabolic surgery | News

Better cardiovascular outcomes with gastric bypass vs sleeve gastrectomy

Among people with type 2 diabetes and obesity who undergo metabolic surgery, Roux-en-Y gastric bypass is associated with a lower risk for major adverse cardiovascular events than sleeve gastrectomy, suggests a secondary analysis of a cohort study.

09-02-2021 | Type 2 diabetes | News

Consensus report defines type 2 diabetes remission criteria

An international expert group organized by the ADA has published consensus definitions of type 2 diabetes remission.

07-09-2021 | Obesity | News

Brain MRI offers clues to weight regain after surgery vs diet

Divergent changes in brain activity after bariatric surgery versus a very-low-calorie diet may help explain why people are more likely to regain weight after the latter intervention, a study suggests.

07-07-2021 | ADA 2021 | Conference coverage | News

​​​​​​​Better 5-year outcomes for RYGB with silastic ring vs sleeve gastrectomy in type 2 diabetes

People with obesity are more likely to achieve sustained remission of type 2 diabetes if they undergo Roux-en-Y gastric bypass with a silastic band rather than sleeve gastrectomy, show the 5-year findings of a randomized trial.

Surgery

05-19-2021 | Semaglutide | News

Semaglutide boosts weight loss of minimally invasive gastric procedure

Giving semaglutide to people undergoing minimally invasive endoscopic sleeve gastroplasty may bring weight loss closer to that induced by bariatric surgery, shows research.

Surgery

05-10-2021 | Metabolic surgery | News

Surgery for type 2 diabetes may restore nearly a decade to life expectancy

A meta-analysis shows that bariatric or metabolic surgery markedly increases life expectancy relative to standard obesity care, with the greatest gains seen for people with type 2 diabetes.

Abdominal surgery

01-25-2021 | Metabolic surgery | News

Glycemic benefits of metabolic surgery endure for at least 10 years

Metabolic surgery can result in type 2 diabetes remission lasting for at least 10 years, and people who relapse still achieve markedly improved glycemic control, shows follow-up from a randomized trial published in The Lancet.

Gastric bypass surgery (used with permission)

12-14-2020 | Metabolic surgery | News

Support for bariatric surgery in people with insulin-dependent type 2 diabetes

Treatment with bariatric surgery is associated with clinical and cost-saving benefits among obese people with type 2 diabetes requiring insulin, researchers report.

10-13-2020 | Metabolic surgery | News

Bariatric surgery cuts pancreatic cancer risk in obese individuals with diabetes

Bariatric surgery is associated with a reduced prevalence of pancreatic cancer in obese individuals with type 2 diabetes, suggest findings from a population-based study presented at UEG Week Virtual 2020.

10-12-2020 | Metabolic surgery | News

Duodenal mucosal resurfacing offers insulin-free hope for patients with type 2 diabetes

Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonists could enable some people with type 2 diabetes to discontinue insulin therapy, suggest findings from the pilot INSPIRE study.

Bariatric surgery

08-19-2020 | Metabolic surgery | News

‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes

Among people with obesity and type 2 diabetes, substantial weight loss is associated with similar metabolic benefits irrespective of whether it is achieved through gastric bypass surgery or diet, suggests research published in The New England Journal of Medicine.

03-24-2020 | Metabolic surgery | News

Gastric bypass benefits are wide-ranging and universally applicable in type 2 diabetes

Weight loss after gastric bypass surgery results in important cardiovascular and renal benefits for obese people with type 2 diabetes, irrespective of their baseline renal function, observational cohort study data show.